Quanterix Corporation (QTRX)
NASDAQ: QTRX · Real-Time Price · USD
3.670
-0.250 (-6.38%)
At close: Jul 24, 2026, 4:00 PM EDT
3.680
+0.010 (0.27%)
After-hours: Jul 24, 2026, 7:55 PM EDT
Quanterix Revenue
Quanterix had revenue of $36.42M in the quarter ending March 31, 2026, with 20.05% growth. This brings the company's revenue in the last twelve months to $144.98M, up 6.85% year-over-year. In the year 2025, Quanterix had annual revenue of $138.90M with 1.07% growth.
Revenue (ttm)
$144.98M
Revenue Growth
+6.85%
P/S Ratio
1.19
Revenue / Employee
$322,176
Employees
450
Market Cap
172.88M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 138.90M | 1.48M | 1.07% |
| Dec 31, 2024 | 137.42M | 15.05M | 12.30% |
| Dec 31, 2023 | 122.37M | 16.85M | 15.96% |
| Dec 31, 2022 | 105.52M | -5.03M | -4.55% |
| Dec 31, 2021 | 110.56M | 24.18M | 27.99% |
| Dec 31, 2020 | 86.38M | 29.64M | 52.25% |
| Dec 31, 2019 | 56.73M | 19.10M | 50.76% |
| Dec 31, 2018 | 37.63M | 14.76M | 64.52% |
| Dec 31, 2017 | 22.87M | 5.29M | 30.08% |
| Dec 31, 2016 | 17.59M | 5.41M | 44.38% |
| Dec 31, 2015 | 12.18M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Inogen | 351.50M |
| Neuronetics | 151.64M |
| InfuSystem Holdings | 142.40M |
| RxSight | 127.48M |
| Owlet | 107.06M |
| AVITA Medical | 72.35M |
| CVRx, Inc. | 59.07M |
| Apyx Medical | 55.90M |
QTRX News
- 8 days ago - Quanterix Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 10 days ago - Anthem Blue Cross, Blue Shield establish commercial coverage for LucentAD - TheFly
- 10 days ago - Anthem Blue Cross and Blue Shield Establishes Commercial Coverage for LucentAD® Complete; Quanterix to Present New Data Highlighting Multi-Analyte Advantages - Business Wire
- 5 weeks ago - Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 6 weeks ago - Quanterix Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 6 weeks ago - Quanterix appoints Faessler as Chief Financial Officer - TheFly
- 6 weeks ago - Quanterix Announces Appointment of Jason Faessler as Chief Financial Officer - Business Wire
- 7 weeks ago - Quanterix appoints Geoff Albrecht as general manager, Diagnostics - TheFly